This is early beta for now! Can't handle all templates properly
Hankkija
Vastaanotettu Hilmaan | 2023-10-04 |
Ilmoituksen numero | 2023-137848 |
TED numero | 2023/S 194-607757 |
Ostajaorganisaatio | Ministry of Social Affairs and Health (0244685-8 ) P.O. BOX 33 FI-00023 Helsinki https://stm.fi/en/frontpage |
Hankinnan otsikkotiedot | Pneumococcal vaccine for risk groups 2024 (2025, 2026 and 2027) |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio | |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen | 1 554 740 EUR |
Alkuperäinen ilmoitus | https://www.hankintailmoitukset.fi/fi/public/procurement/85555/notice/137848/overview |
Originaali JSON tietue | 137848.json |
Ostettava
Hankinnan lyhyt kuvaus | The purpose of STM and the Customer was to procure Pneumococcal Vaccines for risk groups required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for patients 74-year-old and under according to vaccine's Summary of Product Characteristics (SPC). Target group for risk group vaccinations is patients under 75-year-old with severe chronic disease (for example kidney disease or severe lung disease). Finnish Institute for Health and Welfare reserves the right to change and update the definition of risk groups when needed. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet The Customer will implement the procurement on behalf of STM. |
Hankintanimikkeistö (CPV) pää | Vaccines (33651600) |
Hankintanimikkeistö (CPV) muut | Pharmaceutical products (33600000) General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000) |
Aluekoodi | FI |
Pääasiallinen suorituspaikka |
Sopimukset
Päätös päivämäärä | 2023-09-06 |
Sopimusnumero | 1 |
Myyjät | Pfizer Oy (FI), 0194053-9 |